Sinnakannu et al. reported that high SRSF1 expression in chronic myeloid leukemia was associated with imatinib resistance, which was mediated by the SRSF1/PRKCH/PLCH1 axis [24]. Here, PLCH1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.